362 related articles for article (PubMed ID: 15497658)
1. Therapy for the syndromes of GH excess.
Arosio M; Cannavò S; Epaminonda P; Ronchi C; Chiodini I; Adda G
J Endocrinol Invest; 2003; 26(10 Suppl):36-43. PubMed ID: 15497658
[TBL] [Abstract][Full Text] [Related]
2. Acromegaly.
Scacchi M; Cavagnini F
Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
[TBL] [Abstract][Full Text] [Related]
3. Hormonal diagnosis of GH hypersecretory states.
Grottoli S; Gasco V; Ragazzoni F; Ghigo E
J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
[TBL] [Abstract][Full Text] [Related]
4. Guidelines for the diagnosis and treatment of acromegaly: a Canadian perspective.
Patel YC; Ezzat S; Chik CL; Rorstad OP; Serri O; Ur E; Wilkins GE
Clin Invest Med; 2000 Jun; 23(3):172-87. PubMed ID: 10911548
[TBL] [Abstract][Full Text] [Related]
5. Drug insight: Primary medical therapy of acromegaly.
Katznelson L
Nat Clin Pract Endocrinol Metab; 2006 Feb; 2(2):109-17; quiz following 117. PubMed ID: 16932265
[TBL] [Abstract][Full Text] [Related]
6. Gamma-knife surgery is effective in normalising plasma insulin-like growth factor I in patients with acromegaly.
Gutt B; Wowra B; Alexandrov R; Uhl E; Schaaf L; Stalla GK; Schopohl J
Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):219-24. PubMed ID: 15891958
[TBL] [Abstract][Full Text] [Related]
7. Acromegaly - evolving strategies.
Popovic V
Pediatr Endocrinol Rev; 2004 Aug; 1 Suppl 3():496-500. PubMed ID: 16444181
[TBL] [Abstract][Full Text] [Related]
8. Treatment of persistent and recurrent acromegaly.
Del Porto LA; Liubinas SV; Kaye AH
J Clin Neurosci; 2011 Feb; 18(2):181-90. PubMed ID: 21167718
[TBL] [Abstract][Full Text] [Related]
9. Pathology of acromegaly.
Horvath E; Kovacs K
Neuroendocrinology; 2006; 83(3-4):161-5. PubMed ID: 17047379
[TBL] [Abstract][Full Text] [Related]
10. The place of medical treatment of acromegaly: current status and perspectives.
Jallad RS; Bronstein MD
Expert Opin Pharmacother; 2013 Jun; 14(8):1001-15. PubMed ID: 23600991
[TBL] [Abstract][Full Text] [Related]
11. New therapeutic options for acromegaly.
Arosio M; Ronchi CL; Epaminonda P; di Lembo S; Adda G
Minerva Endocrinol; 2004 Dec; 29(4):225-39. PubMed ID: 15765031
[TBL] [Abstract][Full Text] [Related]
12. Review of current and emerging treatment options in acromegaly.
Muhammad A; van der Lely AJ; Neggers SJ
Neth J Med; 2015 Oct; 73(8):362-7. PubMed ID: 26478545
[TBL] [Abstract][Full Text] [Related]
13. An audit of treatment outcome in acromegalic patients attending our center at Bergamo, Italy.
Attanasio R; Montini M; Valota M; Cortesi L; Barbò R; Biroli F; Tonnarelli G; Albizzi M; Testa RM; Pagani G
Pituitary; 2008; 11(1):1-11. PubMed ID: 17690987
[TBL] [Abstract][Full Text] [Related]
14. The PPAR-gamma activator rosiglitazone fails to lower plasma growth hormone and insulin-like growth factor-1 levels in patients with acromegaly.
Bastemir M; Akin F; Yaylali GF
Neuroendocrinology; 2007; 86(2):119-23. PubMed ID: 17671378
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological options in the treatment of acromegaly.
Ezzat S
Curr Opin Investig Drugs; 2005 Oct; 6(10):1023-7. PubMed ID: 16259223
[TBL] [Abstract][Full Text] [Related]
16. Treatment outcomes and mortality of 94 patients with acromegaly.
Trepp R; Stettler C; Zwahlen M; Seiler R; Diem P; Christ ER
Acta Neurochir (Wien); 2005 Mar; 147(3):243-51; discussion 250-1. PubMed ID: 15627919
[TBL] [Abstract][Full Text] [Related]
17. Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution.
Jallad RS; Musolino NR; Salgado LR; Bronstein MD
Clin Endocrinol (Oxf); 2005 Aug; 63(2):168-75. PubMed ID: 16060910
[TBL] [Abstract][Full Text] [Related]
18. Medical therapy in patients with acromegaly: predictors of response and comparison of efficacy of dopamine agonists and somatostatin analogues.
Sherlock M; Fernandez-Rodriguez E; Alonso AA; Reulen RC; Ayuk J; Clayton RN; Holder G; Sheppard MC; Bates A; Stewart PM
J Clin Endocrinol Metab; 2009 Apr; 94(4):1255-63. PubMed ID: 19158203
[TBL] [Abstract][Full Text] [Related]
19. Gamma knife radiosurgery for acromegaly--long-term experience.
Jezková J; Marek J; Hána V; Krsek M; Weiss V; Vladyka V; Lisák R; Vymazal J; Pecen L
Clin Endocrinol (Oxf); 2006 May; 64(5):588-95. PubMed ID: 16649981
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of acromegaly in Aarhus University Hospital. A retrospective investigation of the period from 1994 to 2004].
Madsen M; Matthiesen EB; Poulsen PL; Weeke J; Astrup J; Jørgensen JO
Ugeskr Laeger; 2007 Mar; 169(10):907-10. PubMed ID: 17359734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
